Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Connor Lynch

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
European Journal of Cancer (Oxford, England : 1990)|August 6, 2024
Safety of combined ablative radiotherapy and immune checkpoint inhibitors in three phase I trialsConnor Lynch, Mark C Korpics, Rohan R Katipally, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
A conserved logic for the development of cortical layering in tetrapodsAstrid Deryckere, Saket Choudhary, Connor Lynch, et al.
Scientific Reports|September 17, 2016
Identification of Doxorubicin as an Inhibitor of the IRE1α-XBP1 Axis of the Unfolded Protein ResponseDadi Jiang, Connor Lynch, Bruno C Medeiros, et al.
Clinical and Translational Radiation Oncology|November 12, 2024
Primary site stereotactic ablative body radiotherapy in localized, recurrent, and metastatic renal cell carcinomaDaniel Huang, Connor Lynch, Lucas M Serra, et al.
JAMA Oncology|May 15, 2025
Patient-Reported Outcomes With Stereotactic Intensity Modulated Radiotherapy After Radical Prostatectomy: A Nonrandomized Clinical TrialJohn Nikitas, Leslie K Ballas, Tahmineh Romero, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
European Journal of Cancer (Oxford, England : 1990)|August 6, 2024
Safety of combined ablative radiotherapy and immune checkpoint inhibitors in three phase I trialsConnor Lynch, Mark C Korpics, Rohan R Katipally, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
A conserved logic for the development of cortical layering in tetrapodsAstrid Deryckere, Saket Choudhary, Connor Lynch, et al.
Scientific Reports|September 17, 2016
Identification of Doxorubicin as an Inhibitor of the IRE1α-XBP1 Axis of the Unfolded Protein ResponseDadi Jiang, Connor Lynch, Bruno C Medeiros, et al.
Clinical and Translational Radiation Oncology|November 12, 2024
Primary site stereotactic ablative body radiotherapy in localized, recurrent, and metastatic renal cell carcinomaDaniel Huang, Connor Lynch, Lucas M Serra, et al.
JAMA Oncology|May 15, 2025
Patient-Reported Outcomes With Stereotactic Intensity Modulated Radiotherapy After Radical Prostatectomy: A Nonrandomized Clinical TrialJohn Nikitas, Leslie K Ballas, Tahmineh Romero, et al.
Pageof 2